Though HDAC inhibitors have not been approved by FDA to treat colon cancer, some preclinical studies have discovered its efficacy to treat colon cancer in vitro and in vivo (Kang et al., 2009; Asklund et al., 2012; Yao et al., 2014). The gene discussed is HDAC9; the disease is malignant colon neoplasm.